Page last updated: 2024-08-18

quinuclidines and Carcinoma, Non-Small Cell Lung

quinuclidines has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (14.29)	29.6817
2010's	5 (71.43)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Arunrungvichian, K; Doungchawee, J; Pongrakhananon, V; Pothongsrisit, S; Vajragupta, O; Witayateeraporn, W	1
Enomoto, N; Fujisawa, T; Hayakawa, H; Imokawa, S; Inui, N; Karayama, M; Koshimizu, N; Kuroishi, S; Kusagaya, H; Matsuda, H; Nakamura, Y; Shirai, T; Suda, T; Toyoshima, M; Yamada, T; Yokomura, K	1
Deben, C; Deschoolmeester, V; Jacobs, J; Lardon, F; Op de Beeck, K; Pauwels, P; Peeters, M; Rolfo, C; Van den Bossche, J; Van Der Steen, N; Wouters, A	1
Cao, R; Dong, X; Huang, J; Liu, L	1
Bergmeier, S; Malki, A	1
He, X; Hua, N; Liu, X; Ma, X; Wang, L; Wei, X; Yan, H; Zhao, Z; Zheng, J; Zhong, B; Zhuo, R	1
Bergman, J; Bykov, VJ; Selivanova, G; Stridh, H; Westman, J; Wiman, KG; Zache, N	1

Trials

2 trial(s) available for quinuclidines and Carcinoma, Non-Small Cell Lung

Article	Year
Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2015, Volume: 90, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Female; Humans; Isoquinolines; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Odds Ratio; Palonosetron; Quinuclidines; Treatment Outcome; Vomiting	2015
Palonosetron for prevention of acute and delayed nausea and vomiting in non-small-cell lung carcinoma patients. Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:4 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Humans; Isoquinolines; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Ondansetron; Palonosetron; Quinuclidines; Vomiting	2011

Article

Year

Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancer.

Lung cancer (Amsterdam, Netherlands), 2015, Volume: 90, Issue:3

Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Female; Humans; Isoquinolines; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Odds Ratio; Palonosetron; Quinuclidines; Treatment Outcome; Vomiting

2015

Palonosetron for prevention of acute and delayed nausea and vomiting in non-small-cell lung carcinoma patients.

Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:4

Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Humans; Isoquinolines; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Ondansetron; Palonosetron; Quinuclidines; Vomiting

2011

Other Studies

5 other study(ies) available for quinuclidines and Carcinoma, Non-Small Cell Lung

Article	Year
α7-Nicotinic acetylcholine receptor antagonist QND7 suppresses non-small cell lung cancer cell proliferation and migration via inhibition of Akt/mTOR signaling. Biochemical and biophysical research communications, 2020, 01-22, Volume: 521, Issue:4 Topics: alpha7 Nicotinic Acetylcholine Receptor; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Inhibitory Concentration 50; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Quinuclidines; Signal Transduction; TOR Serine-Threonine Kinases; Triazoles	2020
APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines. Cancer letters, 2016, Jun-01, Volume: 375, Issue:2 Topics: Antineoplastic Agents; Apoptosis; BRCA1 Protein; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinuclidines; Tumor Suppressor Protein p53	2016
Differential apoptotic effects of novel quinuclidinone analogs 8a and 8b in normal and lung cancer cell lines. Anticancer research, 2011, Volume: 31, Issue:4 Topics: Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Cycle; Cell Proliferation; Cells, Cultured; Flow Cytometry; Fluorescent Antibody Technique; Gamma Rays; Humans; Lung; Lung Neoplasms; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Quinuclidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sphingomyelin Phosphodiesterase; Tumor Suppressor Protein p53	2011
A novel muscarinic antagonist R2HBJJ inhibits non-small cell lung cancer cell growth and arrests the cell cycle in G0/G1. PloS one, 2012, Volume: 7, Issue:12 Topics: Animals; Antineoplastic Agents; Benzyl Alcohols; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Evaluation, Preclinical; Female; G1 Phase; Guinea Pigs; Humans; Lung Neoplasms; Models, Biological; Muscarinic Antagonists; Quinuclidines; Resting Phase, Cell Cycle	2012
PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis. Oncogene, 2005, May-12, Volume: 24, Issue:21 Topics: Adenocarcinoma; Animals; Apoptosis; Aza Compounds; Bone Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Interactions; Drug Resistance, Neoplasm; Genes, p53; Humans; Lung Neoplasms; Mice; Mice, SCID; Mutation; Osteosarcoma; Quinuclidines; Transplantation, Heterologous; Tumor Cells, Cultured	2005